Geode Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.98M Buy
2,030,891
+36,847
+2% +$90.3K ﹤0.01% 2732
2025
Q1
$13.3M Buy
1,994,044
+241,069
+14% +$1.61M ﹤0.01% 2119
2024
Q4
$22M Buy
1,752,975
+135,109
+8% +$1.7M ﹤0.01% 1913
2024
Q3
$29.9M Buy
1,617,866
+14,256
+0.9% +$263K ﹤0.01% 1755
2024
Q2
$34.5M Buy
1,603,610
+101,023
+7% +$2.18M ﹤0.01% 1610
2024
Q1
$40.5M Buy
1,502,587
+45,337
+3% +$1.22M ﹤0.01% 1497
2023
Q4
$43.7M Buy
1,457,250
+217,090
+18% +$6.51M ﹤0.01% 1429
2023
Q3
$25.4M Buy
1,240,160
+56,057
+5% +$1.15M ﹤0.01% 1666
2023
Q2
$23.5M Buy
1,184,103
+28,364
+2% +$564K ﹤0.01% 1746
2023
Q1
$19.8M Buy
1,155,739
+54,419
+5% +$932K ﹤0.01% 1809
2022
Q4
$21.6M Buy
1,101,320
+242,101
+28% +$4.74M ﹤0.01% 1727
2022
Q3
$13.7M Buy
859,219
+50,756
+6% +$810K ﹤0.01% 2014
2022
Q2
$11.1M Buy
808,463
+59,726
+8% +$822K ﹤0.01% 2173
2022
Q1
$11.9M Sell
748,737
-5,890
-0.8% -$93.4K ﹤0.01% 2241
2021
Q4
$16.5M Buy
754,627
+2,766
+0.4% +$60.4K ﹤0.01% 2089
2021
Q3
$22.5M Buy
751,861
+9,974
+1% +$298K ﹤0.01% 1877
2021
Q2
$32.9M Buy
741,887
+55,498
+8% +$2.46M ﹤0.01% 1644
2021
Q1
$30.5M Buy
686,389
+85,749
+14% +$3.8M ﹤0.01% 1593
2020
Q4
$32.9M Buy
600,640
+69,608
+13% +$3.82M 0.01% 1393
2020
Q3
$12.1M Sell
531,032
-18,016
-3% -$412K ﹤0.01% 1841
2020
Q2
$11.5M Buy
549,048
+29,592
+6% +$619K ﹤0.01% 1847
2020
Q1
$7.25M Buy
519,456
+51,151
+11% +$714K ﹤0.01% 1929
2019
Q4
$10.7M Buy
468,305
+3,654
+0.8% +$83.2K ﹤0.01% 1970
2019
Q3
$5.41M Buy
464,651
+20,837
+5% +$243K ﹤0.01% 2338
2019
Q2
$6.66M Buy
443,814
+112,660
+34% +$1.69M ﹤0.01% 2216
2019
Q1
$5.81M Buy
331,154
+34,122
+11% +$598K ﹤0.01% 2244
2018
Q4
$4.4M Buy
297,032
+74,923
+34% +$1.11M ﹤0.01% 2295
2018
Q3
$5.47M Buy
222,109
+84,135
+61% +$2.07M ﹤0.01% 2301
2018
Q2
$2.71M Buy
137,974
+57,496
+71% +$1.13M ﹤0.01% 2686
2018
Q1
$1.51M Buy
+80,478
New +$1.51M ﹤0.01% 2921
2017
Q4
Sell
-25,741
Closed -$183K 4036
2017
Q3
$183K Hold
25,741
﹤0.01% 3696
2017
Q2
$195K Sell
25,741
-7,841
-23% -$59.4K ﹤0.01% 3697
2017
Q1
$268K Buy
33,582
+877
+3% +$7K ﹤0.01% 3547
2016
Q4
$797K Buy
32,705
+1,464
+5% +$35.7K ﹤0.01% 3100
2016
Q3
$1.18M Buy
31,241
+5,416
+21% +$205K ﹤0.01% 2854
2016
Q2
$768K Buy
25,825
+5,307
+26% +$158K ﹤0.01% 3022
2016
Q1
$607 Sell
20,518
-14
-0.1% ﹤0.01% 3120
2015
Q4
$930K Buy
20,532
+733
+4% +$33.2K ﹤0.01% 2942
2015
Q3
$744K Buy
19,799
+12,397
+167% +$466K ﹤0.01% 3045
2015
Q2
$145K Buy
+7,402
New +$145K ﹤0.01% 3675